About MeI’m a neurosurgeon, the clinical director of Ohio State’s Spinal Biodynamics and Ergonomics Laboratory, and a professor of neurosurgery, oncology, orthopedics and integrated engineering. My area of specialtity is in spinal tumors as the Director of the OSUCCC – James spine program. I am proud to be at the OSUCCC - James, where we consistently strive to bring top-level care to patients and increase their likelihood of cancer survival.
I was a member of the Spine Oncology Study Group, a group of physicians developing guidelines for the management of spine tumors. I recently led a multidisciplinary team that pioneered a new surgical technique to protect the spine following surgery to remove bone tumors. Removing these tumors intact is challenging but very important for a successful surgery. This and other groundbreaking research at Ohio State is a key to better outcomes and longer lifespans for cancer patients.
My dedication to medical research led me to establish the first accredited complex and oncological spine fellowship program at Ohio State, which has received numerous academic grants of support. I’ve published mroe than 20 book chapters and more than 100 journal articles, contributed to numerous peer-reviewed reference works, and I regularly deliver presentations on spinal tumor-related topics, both nationally and internationally.
- Named to the Castle Connolly list of America’s “Top Doctors” for 2017
- Best Doctor in America 2017
Additional languages I speak
Specialties and conditions I treat
- Neurological Surgery
- Brain Cancers
- Spinal Cancers
- Sarcoma, Kaposi
Locations where I practice
Education and training
Louisiana State University School of Med
University of Southern California Medical Center
7/1/1992 - 6/13/1998
More about my work
University of Florida School of Medicine
7/1/1996 - 6/13/1997
American Board of Neurological Surgery
News about me
Consulting and Related Relationships
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 03/28/2017, Dr. Mendel has reported financial relationships with the medical device, research and/or drug companies listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office at 614-293-7802.
- K2m, Inc.
- Johnson & Johnson